There are 27 resources available
Introduction and Objectives
Presenter: P. A. Jänne, US and S. Peters, CH
Session: Opening and Welcome
Resources:
Slides
Webcast
Early Detection of Lung Cancer: Biology, Screening and Cost-Effectiveness
Presenter: H. Ashraf, NO
Session: Session 1 – Screening, Diagnosis, and Staging
Resources:
Slides
Webcast
The Role of Pathology and Genetic/Molecular Analyses for Primary Cancer Diagnostics
Presenter: P. Micke, SE
Session: Session 1 – Screening, Diagnosis, and Staging
Resources:
Slides
Webcast
Adjuvant and Neo-Adjuvant Chemotherapy, Radiotherapy Targeted and Immunotherapeutic Agents: Clinical Evidence and Clinical Research
Presenter: E. Felip, ES
Session: Session 2 – Adjuvant Therapy
Resources:
Slides
Webcast
Management of Stage III - Case Presentation
Presenter: I. J. Z. Eide, NO, I. Ilonen, FI, J. Nyman, SE, Å. Helland, NO
Session: Session 3 – Multi-disciplinary lung tumour board – Part I
Resources:
Slides
Webcast
Management of Oligometastatic Disease - Case Presentation
Presenter: I. Ilonen, FI, K. Lindberg, SE, J. B. Sørensen, DK
Session: Session 4 – Multi-disciplinary lung tumour board – Part II
Resources:
Slides
Webcast
Participants Clinical Case Discussion - Navigating Complexities: A Case of Adenosquamous Lung Carcinoma with Multimodal Therapy Challenges
Presenter: A. Ali, UK
Session: Session 5 – Audience Cases
Resources:
Slides
Webcast
Participants Clinical Case Discussion - Immune Checkpoint Inhibitor-Related Autoimmune Gastritis in a Case with Lung Adenocarcinoma
Presenter: E. Çerme, TR
Session: Session 5 – Audience Cases
Resources:
Slides
Webcast
Participants Clinical Case Discussion - Classical EGFR Mutation Joined by RET Fusion over Time
Presenter: M. Collienne, DE
Session: Session 5 – Audience Cases
Resources:
Slides
Webcast
Participants Clinical Case Discussion - Targeting the Driver or Unleashing the Immune System: Sequencing Therapeutics in BRAF-Mutated and PDL1-Positive NSCLC
Presenter: J. Correia, PT
Session: Session 5 – Audience Cases
Resources:
Slides
Webcast